Signalling pathways involved in urotensin II induced ventricular myocyte hypertrophy

Signalling pathways involved in urotensin II induced ventricular myocyte hypertrophy

Saved in:

Bibliographic Details
Main Authors:	Hadeel S. Al Ali, Glenn C. Rodrigo, David G. Lambert
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2025-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11737703/?tool=EBI
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

ATP-Sensitive Potassium Channel Currents in Eccentrically Hypertrophied Cardiac Myocytes of Volume-Overloaded Rats
by: Zikiar V. Alvin, et al.
Published: (2011-01-01)

The effects of the urotensin-II receptor antagonist palosuran treatment on the corpora cavernosa of streptozotocin-induced diabetic rats
by: Murat Olukman, et al.
Published: (2025-01-01)

Renal Urotensin II System Plays Roles in the Regulation of Blood Pressure in Dahl Salt-Resistant Rat
by: Fei Wu, et al.
Published: (2016-01-01)

Marked Regression of Left Ventricular Hypertrophy after Outflow Desobliteration in HOCM
by: Zisis Dimitriadis, et al.
Published: (2012-01-01)

Chemical Feature-Based Molecular Modeling of Urotensin-II Receptor Antagonists: Generation of Predictive Pharmacophore Model for Early Drug Discovery
by: Anubhuti Pandey, et al.
Published: (2014-01-01)

Albuminuria Is Associated with Left Ventricular Hypertrophy in Patients with Early Diabetic Kidney Disease
by: Nan Wu, et al.
Published: (2014-01-01)

Inhibitory Effect of Cinobufagin on L-Type Ca2+ Currents, Contractility, and Ca2+ Homeostasis of Isolated Adult Rat Ventricular Myocytes
by: Pinya Li, et al.
Published: (2014-01-01)

20-HETE mediates Ang II-induced cardiac hypertrophy via ROS and Ca2+ signaling in H9c2 cells
by: Jingyi Han, et al.
Published: (2025-01-01)

Image Processing Techniques for Assessing Contractility in Isolated Adult Cardiac Myocytes
by: Carlos Bazan, et al.
Published: (2009-01-01)

The Value of Four Anthropometric Indicators for Identifying Left Ventricular Hypertrophy in Chinese Hypertensive Patients
by: Bokai Cheng, et al.
Published: (2022-01-01)

Anti-Interleukin-22-Neutralizing Antibody Attenuates Angiotensin II-Induced Cardiac Hypertrophy in Mice
by: Jing Ye, et al.
Published: (2017-01-01)

Notch Signaling Pathway Is Involved in bFGF-Induced Corneal Lymphangiogenesis and Hemangiogenesis
by: Fang Xie, et al.
Published: (2019-01-01)

Interleukin-4 Promotes Myogenesis and Boosts Myocyte Insulin Efficacy
by: Yih-Hsin Chang, et al.
Published: (2019-01-01)

Erratum to “Anti-Interleukin-22-Neutralizing Antibody Attenuates Angiotensin II-Induced Cardiac Hypertrophy in Mice”
by: Jing Ye, et al.
Published: (2018-01-01)

Predictive value of epicardial fat thickness for left ventricular reverse remodeling after radiofrequency ablation in atrial fibrillation patients with left ventricular hypertrophy
by: Ke Hu, et al.
Published: (2025-01-01)

Effects of IGF-1 on IK and IK1 Channels via PI3K/Akt Signaling in Neonatal Cardiac Myocytes
by: Richard M. Millis, et al.
Published: (2012-01-01)

Assessment of ECG Criteria for the Diagnosis of Right Ventricular Involvement
by: Suhaib Al-Mashari, et al.
Published: (2024-07-01)

Impact of Preventive Intravenous Amiodarone on Reperfusion Ventricular Fibrillation in Patients With Left Ventricular Hypertrophy Undergoing Open-Heart Surgery: Randomized Controlled Clinical Trial
by: Chan-Juan Gong, et al.
Published: (2025-01-01)

Pre-Conditioning with CDP-Choline Attenuates Oxidative Stress-Induced Cardiac Myocyte Death in a Hypoxia/Reperfusion Model
by: Héctor González-Pacheco, et al.
Published: (2014-01-01)

The Polymorphism of the ACE Gene Affects Left Ventricular Hypertrophy and Causes Disturbances in Left Ventricular Systolic/Diastolic Function in Patients with Autosomal Dominant Polycystic Kidney Disease
by: Maria Wanic-Kossowska, et al.
Published: (2014-01-01)

Length and PKA Dependence of Force Generation and Loaded Shortening in Porcine Cardiac Myocytes
by: Kerry S. McDonald, et al.
Published: (2012-01-01)

A Reduction in ADAM17 Expression Is Involved in the Protective Effect of the PPAR-α Activator Fenofibrate on Pressure Overload-Induced Cardiac Hypertrophy
by: Si-Yu Zeng, et al.
Published: (2018-01-01)

Androgen Effects on the Adrenergic System of the Vascular, Airway, and Cardiac Myocytes and Their Relevance in Pathological Processes
by: Abril Carbajal-García, et al.
Published: (2020-01-01)

Syringaldehyde Alleviates Cardiac Hypertrophy Induced by Hyperglycemia in H9c2 Cells Through GLP-1 Receptor Signals
by: Yingxiao Li, et al.
Published: (2025-01-01)

Epicardial Adipose Tissue and Left Ventricular Hypertrophy in Hypertensive Patients With Preserved Ejection Fraction: A Multicenter Retrospective Cohort Study
by: Runze Zhu, et al.
Published: (2025-01-01)

Redox Signaling in Diabetic Nephropathy: Hypertrophy versus Death Choices in Mesangial Cells and Podocytes
by: Gina Manda, et al.
Published: (2015-01-01)

A Fortified Method to Screen and Detect Left Ventricular Hypertrophy in Asymptomatic Hypertensive Adults: A Korean Retrospective, Cross-Sectional Study
by: Hyo Eun Park, et al.
Published: (2018-01-01)

Myocardium Assessment by Relaxation along Fictitious Field, Extracellular Volume, Feature Tracking, and Myocardial Strain in Hypertensive Patients with Left Ventricular Hypertrophy
by: Seyed Amir Mirmojarabian, et al.
Published: (2022-01-01)

Ginkgolide B Protects Cardiomyocytes from Angiotensin II-Induced Hypertrophy via Regulation of Autophagy through SIRT1-FoxO1
by: Qingyuan Jiang, et al.
Published: (2021-01-01)

Lupeol Attenuates Palmitate-Induced Hypertrophy in 3T3-L1 Adipocytes
by: Vaithinathan Selvaraju, et al.
Published: (2025-01-01)

L-Carnitine Alleviates the Myocardial Infarction and Left Ventricular Remodeling through Bax/Bcl-2 Signal Pathway
by: Hao-Ran Li, et al.
Published: (2022-01-01)

Investigating the role of age, admission systolic blood pressure, and neutrophil-to-lymphocyte ratio in predicting left ventricular hypertrophy among patients with primary hypertension
by: Xiaoyong Hu, et al.
Published: (2025-01-01)

Lipomatous Hypertrophy: An Accidental Finding in Heart
by: F. Petrelli, et al.
Published: (2019-01-01)

Association between serum uric acid levels and left ventricular hypertrophy based on electrocardiographic findings: a sex-specific analysis across cardiometabolic diseases
by: Anwar Ahmed Salim, et al.
Published: (2025-01-01)

Within-individual design for assessing true individual responses in resistance training-induced muscle hypertrophy
by: Talisson Santos Chaves, et al.
Published: (2025-01-01)

Adenotonsillar Hypertrophy as a Cause of Failure to Thrive
by: Ann G Sheehan, et al.
Published: (1990-01-01)

A Case of Clitoral Hypertrophy of Unknown Origin
by: Tetsuya Okaneya, et al.
Published: (2018-01-01)

Targeting Chondrocyte Hypertrophy as Strategies for the Treatment of Osteoarthritis
by: Da-Long Dong, et al.
Published: (2025-01-01)

Involvement of Cholesterol Metabolic Pathways in Recovery from Noise-Induced Hearing Loss
by: Na Sai, et al.
Published: (2020-01-01)

Calcium Signaling in the Ventricular Myocardium of the Goto-Kakizaki Type 2 Diabetic Rat
by: L. Al Kury, et al.
Published: (2018-01-01)